2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.1 - Release 2022.1
2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.1 - Release 2022.1
2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide, published by CDC / Security Risk Solutions, Inc. (SRS). This guide is not an authorized publication; it is the continuous build for version 2022.1.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/security-rs/opioid-cds-r4/ and changes regularly. See the Directory of published versions
| Official URL: http://fhir.org/guides/cdc/opioid-cds/ValueSet/xylazine-urine-drug-screening-tests | Version: 2022.1.1 | |||
| Active as of 2026-06-02 | Computable Name: XYLAZINE_URINE_DRUG_SCREENING_TESTS | |||
| Other Identifiers: OID:2.16.840.1.113883.4.642.40.65.48.69 | ||||
Copyright/Legal: © CDC 2016+. |
||||
Individual tests and panels of tests of urine for xylazine
Identification of xylazine urine drug tests where results can be used when considering opioid therapy
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Profiles: CPGComputableValueSet, CPGExecutableValueSet
This value set includes codes based on the following rules:
http://loinc.org version Not Stated (use latest from terminology server) where concept is-a LP437281-1 (4-hydroxy Xylazine), SYSTEM = LP7681-2 (Urine) and CLASSTYPE = 1http://loinc.org version Not Stated (use latest from terminology server) where concept is-a LP435271-4 (Xylazine), SYSTEM = LP7681-2 (Urine) and CLASSTYPE = 1
Expansion based on Loinc v2.82
This value set contains 7 concepts
| System | Code | Display | JSON | XML |
http://loinc.org | 103638-3 | 4-hydroxy Xylazine [Mass/volume] in Urine by Confirmatory method | ||
http://loinc.org | 103639-1 | 4-hydroxy Xylazine [Presence] in Urine by Confirmatory method | ||
http://loinc.org | 103640-9 | 4-hydroxy Xylazine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ||
http://loinc.org | 101808-4 | Xylazine [Mass/volume] in Urine by Confirmatory method | ||
http://loinc.org | 101809-2 | Xylazine [Presence] in Urine by Confirmatory method | ||
http://loinc.org | 101810-0 | Xylazine/Creatinine [Mass Ratio] in Urine by Confirmatory method | ||
http://loinc.org | 107608-2 | Xylazine [Presence] in Urine |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |